SHAREHOLDERS' EQUITY (Details) - USD ($) $ in Millions		3 Months Ended		6 Months Ended
	Mar. 27, 2015	Jun. 30, 2015	Jun. 30, 2014	Jun. 30, 2015	Jun. 30, 2014
Increase (Decrease) in Shareholders' Equity
Beginning Balance (in shares)				334,402,964
Beginning Balance				$ 5,434.5	$ 5,233.3
Issuance of common stock (in shares)	7,286,432
Issuance of common stock	$ 1,450.0			1,481.0
Common shares issued under share-based compensation plans				22.1	7.2
Settlement of stock options					(3.1)
Repurchases of common shares				(50.0)
Share-based compensation				60.9	40.4
Employee withholding taxes related to share-based awards				(61.5)	(36.5)
Tax benefits from stock options exercised				25.6	1.2
Acquisition of noncontrolling interest					(3.3)
Noncontrolling interest distributions				1.1
Total before comprehensive income (loss)		$ 6,911.5	$ 5,239.2	6,911.5	5,239.2
Comprehensive loss:
Net (loss) income		(51.6)	122.0	22.9	101.7
Other comprehensive loss				(376.0)	26.4
Comprehensive (loss) income		$ (15.7)	156.4	$ (353.1)	128.1
Ending Balance (in shares)		342,769,031		342,769,031
Ending Balance		$ 6,558.4	$ 5,367.3	$ 6,558.4	$ 5,367.3
Common Shares
Increase (Decrease) in Shareholders' Equity
Beginning Balance (in shares)				334,400,000	333,000,000
Beginning Balance				$ 8,349.2	$ 8,301.2
Issuance of common stock (in shares)				7,500,000
Issuance of common stock				$ 1,481.0
Common shares issued under share-based compensation plans (in shares)				1,100,000	800,000
Common shares issued under share-based compensation plans				$ 57.0	$ 24.7
Repurchases of common shares (in shares)				(200,000)
Repurchases of common shares				$ (6.4)
Total before comprehensive income (loss) (in shares)		342,800,000	333,800,000	342,800,000	333,800,000
Total before comprehensive income (loss)		$ 9,880.8	$ 8,325.9	$ 9,880.8	$ 8,325.9
Comprehensive loss:
Ending Balance (in shares)		342,800,000	333,800,000	342,800,000	333,800,000
Ending Balance		$ 9,880.8	$ 8,325.9	$ 9,880.8	$ 8,325.9
Additional Paid-In Capital
Increase (Decrease) in Shareholders' Equity
Beginning Balance				243.9	228.8
Common shares issued under share-based compensation plans				(34.9)	(17.5)
Settlement of stock options					(3.1)
Share-based compensation				60.9	40.4
Employee withholding taxes related to share-based awards				(61.5)	(36.5)
Tax benefits from stock options exercised				25.6	1.2
Acquisition of noncontrolling interest					(1.1)
Total before comprehensive income (loss)		234.0	212.2	234.0	212.2
Comprehensive loss:
Ending Balance		234.0	212.2	234.0	212.2
Accumulated Deficit
Increase (Decrease) in Shareholders' Equity
Beginning Balance				(2,365.0)	(3,278.5)
Repurchases of common shares				(43.6)
Total before comprehensive income (loss)		(2,408.6)	(3,278.5)	(2,408.6)	(3,278.5)
Comprehensive loss:
Net (loss) income				20.7	103.2
Ending Balance		(2,387.9)	(3,175.3)	(2,387.9)	(3,175.3)
Accumulated Other Comprehensive Loss
Increase (Decrease) in Shareholders' Equity
Beginning Balance				(915.9)	(132.8)
Total before comprehensive income (loss)		(915.9)	(132.8)	(915.9)	(132.8)
Comprehensive loss:
Other comprehensive loss				(375.6)	28.1
Ending Balance		(1,291.5)	(104.7)	(1,291.5)	(104.7)
Valeant Pharmaceuticals International, Inc. Shareholders’ Equity
Increase (Decrease) in Shareholders' Equity
Beginning Balance				5,312.2	5,118.7
Issuance of common stock				1,481.0
Common shares issued under share-based compensation plans				22.1	7.2
Settlement of stock options					(3.1)
Repurchases of common shares				(50.0)
Share-based compensation				60.9	40.4
Employee withholding taxes related to share-based awards				(61.5)	(36.5)
Tax benefits from stock options exercised				25.6	1.2
Acquisition of noncontrolling interest					(1.1)
Total before comprehensive income (loss)		6,790.3	5,126.8	6,790.3	5,126.8
Comprehensive loss:
Net (loss) income				20.7	103.2
Other comprehensive loss				(375.6)	28.1
Comprehensive (loss) income				(354.9)	131.3
Ending Balance		6,435.4	5,258.1	6,435.4	5,258.1
Noncontrolling Interest
Increase (Decrease) in Shareholders' Equity
Beginning Balance				122.3	114.6
Acquisition of noncontrolling interest					(2.2)
Noncontrolling interest distributions				1.1
Total before comprehensive income (loss)		121.2	112.4	121.2	112.4
Comprehensive loss:
Net (loss) income				2.2	(1.5)
Other comprehensive loss				(0.4)	(1.7)
Comprehensive (loss) income				1.8	(3.2)
Ending Balance		$ 123.0	$ 109.2	$ 123.0	$ 109.2